Granite FO LLC’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,100
Closed -$35.8K 206
2023
Q1
$35.8K Buy
+4,100
New +$40.5K 0.02% 160

Other funds holding TEVA

Granite FO LLC's TEVA Position: Q2 2023 in Review

Granite FO LLC sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2023, closing a stake of 4,100 shares — an estimated $35.8K sold.

Granite FO LLC first reported a position in TEVA in Q1 2023 and held it in 1 quarter. The position peaked at $35.8K in Q1 2023. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • Granite FO LLC reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2023 after selling out during the quarter.
  • Granite FO LLC sold 4,100 Teva Pharmaceutical Industries Limited shares in Q2 2023, an estimated $35.8K.
  • Granite FO LLC first reported a position in Teva Pharmaceutical Industries Limited in Q1 2023 and held it in 1 quarter.
  • Granite FO LLC's Teva Pharmaceutical Industries Limited position peaked at $35.8K in Q1 2023.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2023.

Based on Granite FO LLC's 13F filing for Q2 2023, filed 5 Sep 2024.